Evidence for Positive Selection Driving the Evolution of HIV-1 env under Potent Antiviral Therapy
- 1 June 2001
- Vol. 284 (2) , 250-258
- https://doi.org/10.1006/viro.2000.0887
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Residual Human Immunodeficiency Virus (HIV) Type 1 RNA and DNA in Lymph Nodes and HIV RNA in Genital Secretions and in Cerebrospinal Fluid after Suppression of Viremia for 2 YearsThe Journal of Infectious Diseases, 2001
- Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapyNature Medicine, 1999
- Parallel evolution of drug resistance in HIV: failure of nonsynonymous/synonymous substitution rate ratio to detect selectionMolecular Biology and Evolution, 1999
- Simultaneous vs Sequential Initiation of Therapy With Indinavir, Zidovudine, and Lamivudine for HIV-1 InfectionJAMA, 1998
- Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibodyNature, 1998
- Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapyProceedings of the National Academy of Sciences, 1997
- Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral TherapyScience, 1997
- Causes of HIV diversityNature, 1995
- Development of a quasispecies of human immunodeficiency virus type 1 in vivo.Proceedings of the National Academy of Sciences, 1992
- A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequencesJournal of Molecular Evolution, 1980